Skip to main content
Premium Trial:

Request an Annual Quote

DiaCarta Colorectal Cancer Test Gets CE-IVD Marking

NEW YORK (GenomeWeb) – Molecular diagnostics firm DiaCarta said yesterday it has received CE-IVD marking for its PCR-based kit to detect mutations associated with colorectal cancer.

The ColoScape test uses DiaCarta's QClamp XNA-based clamping technology and runs on commonly-used real-time PCR platforms in two-and-a-half hours. It requires as little as 20 ng of DNA from formalin-fixed, paraffin embedded tumor, stool, or plasma samples, and it detects 20 DNA mutation markers from four oncogenes, the firm said in a statement.

Study data generated by the company and its collaborators using the kit showed it identified greater than 95 percent of stage I-IV colorectal cancer cases, DiaCarta said.

"CE-IVD approval for the ColoScape kit means we can offer clinicians the ability to screen for CRC mutations from patient samples with the highest level of performance that the clinical setting demands," CEO of DiaCarta, Aiguo Zhang, said. "Our goal is to expand the global reach of this best-in-class clinical product with additional regulatory filings planned later this year and into 2018"

Additionally, the Richmond, California-based firm announced it has launched a CE-marked assay for ALK fusions, the QFusion ALK Fusion Gene Detection kit, which can detect as few as 50 fusion templates in a single reaction.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.